13F

Stock

Alnylam Pharmaceuticals, Inc.

ALNY · held by 5 managers

Reported value

$41.1M

Holders

5

+0 new · −1 exited

Holders’ est. mark

−$1.54M

Price effect on 4 books still in the name

Largest holder

$39.9M

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC210.1K$39.9M−$1.47MAdded$11.6M
Swiss Life Asset Management Ltd4.32K$820.6K−$44.6KCut−$49.6K
Marex Group plc1.33K$253.4K−$13.8KCut−$61.7K
Leonteq Securities AG711$135K−$7.38KCut−$26.6K
AEGON ASSET MANAGEMENT UK Plc9$2KHeld

Who left

Positions as of Q2 2023. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.